Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

[1]  J. Fung,et al.  Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  J. Sánchez-Tapias,et al.  Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation , 2000, Hepatology.

[3]  C. Scudamore,et al.  Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  P. Angus,et al.  Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  F. Baldanti,et al.  Two Sensitive PCR-Based Methods for Detection of Hepatitis B Virus Variants Associated with Reduced Susceptibility to Lamivudine , 1999, Journal of Clinical Microbiology.

[6]  L. Wallace,et al.  Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin. , 1999, Journal of hepatology.

[7]  C. Chu,et al.  Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy , 1999, Hepatology.

[8]  E. Schiff,et al.  Multicenter study of lamivudine therapy for hepatitis B after liver transplantation , 1999, Hepatology.

[9]  P. Angus,et al.  Combination low dose hepatitis B immune globulin (HBIG) and lamivudine therapy provides effective prophylaxis against post transplant hepatitis B , 1999 .

[10]  C. Hunt,et al.  Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients. , 1998 .

[11]  J. Roberts,et al.  Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin , 1998, Hepatology.

[12]  J. Markmann,et al.  Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin , 1998, Hepatology.

[13]  N. Leung,et al.  A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. , 1998, The New England journal of medicine.

[14]  T. Berg,et al.  Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high‐dose hepatitis B immune globulin after liver transplantation , 1998, Hepatology.

[15]  A. Lok,et al.  Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis , 1998, Hepatology.

[16]  A. Dhillon,et al.  Lamivudine and intron a combination treatment in patients with chronic hepatitis B infection , 1998 .

[17]  R. D. de Man,et al.  Lamivudine resistance inimmunocompetent chronic hepatitis B , 1997 .

[18]  R. Repp,et al.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients , 1997, Journal of virology.

[19]  D. Samuel,et al.  Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. , 1997, Journal of hepatology.

[20]  J. Roberts,et al.  Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin , 1996, Hepatology.

[21]  F. Chisari,et al.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.

[22]  M. Manns,et al.  Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis , 1996, Hepatology.

[23]  Roger Williams,et al.  Hepatitis B envelope protein mutants , 1995, The Lancet.

[24]  Mark George Thomas,et al.  Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment. , 1995, Gastroenterology.

[25]  G. Alexander,et al.  'EUROHEP' consensus report on the management of liver transplantation for hepatitis B virus infection. European Concerted Action on Viral Hepatitis. , 1994, Journal of hepatology.

[26]  G. Alexander,et al.  Liver transplantation in European patients with the hepatitis B surface antigen. , 1993, The New England journal of medicine.

[27]  M. Mearns,et al.  Hepatitis B virus DNA in peripheral‐blood mononuclear cells in chronic hepatitis B after HBsAg clearance , 1992, Hepatology.

[28]  S. Davies,et al.  Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. , 1992, Journal of hepatology.

[29]  C. Wittekind,et al.  Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. , 1991, Journal of hepatology.

[30]  D. Samuel,et al.  Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients , 1991, The Lancet.

[31]  D. V. van Thiel,et al.  Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease , 1991, Hepatology.

[32]  G. Alexander,et al.  Detection of hepatitis B virus antigens in liver tissue. A relation to viral replication and histology in chronic hepatitis B infection. , 1990, Gastroenterology.

[33]  D. Samuel,et al.  Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model. , 1990, Transplantation.